Sio Capital Management’s Akari Therapeutics AKTX Stock Holding History

Sio Capital Management’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-23	Closed	-$881K	–	32
2014 Q4	$881K	Buy	+23	New	+$1.01M	0.69%	28

Other funds holding AKTX

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sio Capital Management's AKTX Position: Q1 2015 in Review

Sio Capital Management sold out of Akari Therapeutics (AKTX) in Q1 2015, closing a stake of 23 shares — an estimated $881K sold.

Sio Capital Management first reported a position in AKTX in Q4 2014 and held it in 1 quarter. The position peaked at $881K in Q4 2014. 3 funds tracked by Wall St. Rank hold AKTX as of Q1 2015.

Sio Capital Management reported no remaining Akari Therapeutics position as of Q1 2015 after selling out during the quarter.
Sio Capital Management sold 23 Akari Therapeutics shares in Q1 2015, an estimated $881K.
Sio Capital Management first reported a position in Akari Therapeutics in Q4 2014 and held it in 1 quarter.
Sio Capital Management's Akari Therapeutics position peaked at $881K in Q4 2014.
3 funds tracked by Wall St. Rank held Akari Therapeutics as of Q1 2015.

Based on Sio Capital Management's 13F filing for Q1 2015, filed 15 May 2015.